Mirantus Health Secures €5.5M Seed Round to Expand Eye‑Screening Services

Why It Matters

The capital infusion positions Mirantus Health to capture a sizable, underserved segment of the eye‑care market, potentially reshaping preventive ophthalmology delivery and delivering strong returns for health‑tech investors.

Deal Summary

Berlin‑based healthtech startup Mirantus Health announced a €5.5 million seed funding round. Backers include Revent, Redstone, Entrepreneur First, Noaber and Arve Capital, which will be used to broaden operations and reach underserved eye‑care markets.